http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106995437-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b33dd6f3ada81a293d6202f04929e5d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28fd66b334e4f40baaeccfe8c5e1e93f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efdee1486adaaa8b1a607a9e3ee9d060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bf9c152c6cc1f4625c43ab8e5268f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb60dcb24cffa0cc71132d8ef20b1ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc94c16cf89e8aef29c4b536941ad17a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64b4b54712d5c6593dcbec7fdc616e04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_426e3337c8738cd57d01cc6e890ded92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5754d897822d9c4703d36f117456c361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bbe38ec43370340d7a23407a02b948
publicationDate 2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106995437-A
titleOfInvention Substituted indole or indazole pyrimidine derivatives, preparation method and use thereof
abstract The present invention relates to substituted indole or indazole pyrimidine derivatives and their preparation method, pharmaceutical composition and application. Specifically, it relates to a compound of formula I or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 -R 7 , and the definitions of X and Y are as described in the specification and claims. The present invention also relates to the preparation method of the compound of formula I, including its pharmaceutical composition and their pharmaceutical use. The compound of formula I of the present invention is an effective irreversible inhibitor of tyrosine kinase, especially has strong inhibitory effect on EGFR-T790M drug-resistant tumors.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111303123-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115819406-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111909101-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115819406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111606889-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111606889-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111909101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3793993-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020228635-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109438422-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021244560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020233669-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109280048-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112313223-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110698461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107556293-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112292378-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112480083-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111303123-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019222093-A1
priorityDate 2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102083800-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105461695-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011046370-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011053476-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163492099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410714230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465058213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415738401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148297489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466227617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466551538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467874774

Total number of triples: 55.